Literature DB >> 15299270

The influence of cyclic tension amplitude on chondrocyte matrix synthesis: experimental and finite element analyses.

John T Connelly1, Eric J Vanderploeg, Marc E Levenston.   

Abstract

While not generally viewed as physiologically significant in articular cartilage, substantial tension can develop in fibrocartilage structures and in articular cartilage injuries. This study examined how different amplitudes of cyclic tension influence chondrocyte matrix synthesis. Bovine articular chondrocytes seeded in fibrin gels were loaded continuously for 48 hours at 1.0 Hz with displacements of 5%, 10%, or 20%. Protein and proteoglycan synthesis were measured by (3)H-proline and (35)S-sulfate incorporation, respectively. A poroelastic finite element model of the fibrin gel was developed to determine the strain distributions, hydrostatic pressures, and fluid velocities within the constructs at the various levels of displacement. Compared to unloaded controls, 10% and 20% displacements inhibited proteoglycan synthesis to the same extent, while 5% displacement had no effect. Tensile loading did not significantly affect protein synthesis. The finite element model predicted a wide range of strains and fluid velocities within the region of the gel analyzed for matrix synthesis, and the ranges overlapped for the different levels of displacement. These results indicate that the cyclic tension amplitude influences chondrocyte proteoglycan synthesis and that there may be a threshold in the response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299270

Source DB:  PubMed          Journal:  Biorheology        ISSN: 0006-355X            Impact factor:   1.875


  9 in total

Review 1.  Physical stimulation of chondrogenic cells in vitro: a review.

Authors:  Sibylle Grad; David Eglin; Mauro Alini; Martin J Stoddart
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

2.  The attachments of the temporomandibular joint disc: a biochemical and histological investigation.

Authors:  Vincent P Willard; Boaz Arzi; Kyriacos A Athanasiou
Journal:  Arch Oral Biol       Date:  2011-11-30       Impact factor: 2.633

3.  Using Costal Chondrocytes to Engineer Articular Cartilage with Applications of Passive Axial Compression and Bioactive Stimuli.

Authors:  Le W Huwe; Gurdeep K Sullan; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2017-08-14       Impact factor: 3.845

4.  Genipin-crosslinked fibrin hydrogels as a potential adhesive to augment intervertebral disc annulus repair.

Authors:  R M Schek; A J Michalek; J C Iatridis
Journal:  Eur Cell Mater       Date:  2011-04-18       Impact factor: 3.942

5.  Articular chondrocytes derived from distinct tissue zones differentially respond to in vitro oscillatory tensile loading.

Authors:  E J Vanderploeg; C G Wilson; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2008-04-08       Impact factor: 6.576

Review 6.  Mechanics and mechanobiology of mesenchymal stem cell-based engineered cartilage.

Authors:  Alice H Huang; Megan J Farrell; Robert L Mauck
Journal:  J Biomech       Date:  2009-10-13       Impact factor: 2.712

7.  Optimal 3D culture of primary articular chondrocytes for use in the rotating wall vessel bioreactor.

Authors:  Liliana F Mellor; Travis L Baker; Raquel J Brown; Lindsey W Catlin; Julia Thom Oxford
Journal:  Aviat Space Environ Med       Date:  2014-08

8.  Tension stimulation drives tissue formation in scaffold-free systems.

Authors:  Jennifer K Lee; Le W Huwe; Nikolaos Paschos; Ashkan Aryaei; Courtney A Gegg; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Mater       Date:  2017-06-12       Impact factor: 43.841

9.  Evaluation of the growth environment of a hydrostatic force bioreactor for preconditioning of tissue-engineered constructs.

Authors:  Yvonne Reinwald; Katherine H L Leonard; James R Henstock; Jonathan P Whiteley; James M Osborne; Sarah L Waters; Philippe Levesque; Alicia J El Haj
Journal:  Tissue Eng Part C Methods       Date:  2015-01       Impact factor: 3.056

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.